Goldman Sachs’s HealthCor Catalio Acquisition Corp. Class A Ordinary Shares HCAQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-168,000
Closed -$1.66M 6698
2021
Q2
$1.66M Hold
168,000
﹤0.01% 4370
2021
Q1
$1.68M Buy
+168,000
New +$1.72M ﹤0.01% 4149

Other funds holding HCAQ

Goldman Sachs's HCAQ Position: Q3 2021 in Review

Goldman Sachs sold out of HealthCor Catalio Acquisition Corp. Class A Ordinary Shares (HCAQ) in Q3 2021, closing a stake of 168,000 shares — an estimated $1.66M sold.

Goldman Sachs first reported a position in HCAQ in Q1 2021 and held it in 2 quarters. The position peaked at $1.68M in Q1 2021. 74 funds tracked by Wall St. Rank hold HCAQ as of Q3 2021.

  • Goldman Sachs reported no remaining HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position as of Q3 2021 after selling out during the quarter.
  • Goldman Sachs sold 168,000 HealthCor Catalio Acquisition Corp. Class A Ordinary Shares shares in Q3 2021, an estimated $1.66M.
  • Goldman Sachs first reported a position in HealthCor Catalio Acquisition Corp. Class A Ordinary Shares in Q1 2021 and held it in 2 quarters.
  • Goldman Sachs's HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position peaked at $1.68M in Q1 2021.
  • 74 funds tracked by Wall St. Rank held HealthCor Catalio Acquisition Corp. Class A Ordinary Shares as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.